Advanced search
Publication Cover
Acta Cardiologica Volume 70, 2015 - Issue 2
Submit an article Journal homepage
48
Views
11
CrossRef citations to date
0
Altmetric
Review Article

Heart transplantation in patients with previous malignancy. An overview

Wilhelm Peter MistiaenFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium, and Dept. of Healthcare Sciences, Artesis-Plantijn University College of Antwerp, Antwerp, Belgium.Correspondence[email protected]; [email protected]
, MD, ScD, PhD
Pages 123-130 | Received 18 Sep 2014, Accepted 08 Dec 2014, Published online: 23 May 2017

  • Goldstein DJ, Seldomridge JA, Addonizio L, Rose EA, Oz MC, Michler RE. Orthotopic heart transplantation in patients with treated malignancies. Am J Cardiol 1995; 75:968–971.
  • Penn I.The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742–7.
  • Mehra MR, Kobashigawa J, Starling R, Russel 5, Uber PA, ParameshwarJ, Mohacsi P. Augustine 5, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant 2006; 25: 1024–42.
  • Copeland JG, Emery RW, Levinson MM, Icenog le TB, Carrier M, Ott RA, Copeland JA, McAreer-Rhenman MJ, Nicholson SM. Selection of patients for cardiac transplantation. Circulation 1987; 75: 2–9.
  • de Jonge, N, Kirkels JH, Klöpping C, Lahpor JR, Caliskan K, Maat APWM, Brügemann J, Erasmus ME, Klautz RMJ, Verwey HF, Oomen A, Peels CH, Goliike AEJ, Nicastia D, Koole MAC, Balk AHMM. Guidelines for heart transplantation. Neth Heart J2008; 16:79–87.
  • Dillon TA, Sullivan M, Schätzlein MH, Peterson AC, Scheeringa RH, Clark WR, Ladoswki JS. Cardiac transplantation in patients with preexisting malignancies. Transplantation 1991; 52:82–5.
  • Beaty CA, George TJ, Kilic A, Conte JV, Shah AS. Pre-transplant malignancy: an analysis of outcomes after thoracic organ transplantation. J Heart Lung Transplant 2013; 32: 202–11.
  • Grande AM, Rinaldi M, Sinelli 5, D’Armini AM, Vigano M. Heart transplantation in chemotherapeutic dilated cardiomyopathy. Transplant Proc 2003; 35; 1516–8.
  • Koerner MM, Tenderich G, Minami K, Mannebach H, Koertke H, zu Knyphausen E, El Banayosy A, Bailer D, Kleesiek K, Gleichmann U, Meyer H, Koerfer R. Results of heart transplantation in patients with preexisting malignancies. Am J Cardiol 1997; 79: 988–91.
  • Lenneman AJ, Wang L, Wigger M, Frangoul H, Harrell FE, Silverstein C, Sawyer DB, Lenneman CG. Heart transplant survival outcomes for adriamycin-dilated dardiomyopathy. Am J Cardiol 2013; 111:609–12.
  • Oechslin E, Kiowski W, Schneider J, Follath F, Turina M, Gallino A. Pretransplant malignancy in candidates and posttransplant malignancy in recipients of cardiac transplantation. Ann Oncol 1996; 7: 1059–63.
  • Sig urdardottir V, Bjortuft 0, Eiskjr H, Ekmehag B, Gude E, Gustafsson F, Hagerman I, Halme M, Lommi J, Mared L, Rike GC, Simonsen S. Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies. J Heart Lung Transplant 2012; 31: 1276–80.
  • Ladowski SD, Abel M, Beatty L, Scatena M, Ladowski JS. Long-term follow-up of heart transplant recipients with pre-transplant malignancies. Texas Heart Inst J 2006; 33:27–30.
  • Edwards BS, Hunt SA, Fowler MB, Valantine HA, Stinson EB, Schroeder JS. Cardiac transplantation in patients with preexisting neoplastic diseases. Am J Cardiol 1990; 65:501–4.
  • Taylor DO, Farhoud HH, Kfoury A, Pham 5, Pigula FA, Kormos RL, Renlund DG. Cardiac transplantation in survivors of lymphoma: a multi-institutional survey. Transplantation 2000; 69: 2112–5.
  • Oliveira GH, Hardaway BW, Kucheryavaya AY, Stehlik J, Edwards LB, Taylor DO. Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation. J Heart Lung Transplant 2012; 31: 805–10.
  • Hong RA, limura T, Sumida KN, Eager RM. Cardio-oncology/onco-cardiology. C/in Cardiol 2010; 33:733–7.
  • Steingart RM, Yadav N, Manrique C, Carver JR, Liu J. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management. Semin Oncol 2013; 40:690–708.
  • Handa N, McGregor CGA, Daly RC, Dearani JA, Edwards BS, Frantz RP, Olson U, Rodeheffer RJ. Heart transplantation for radiation-associated, end-stage heart failure. Transplant Int 2000; 13:162–5.
  • Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation 2010; 122: 173–83.
  • Conraads VM, Denollet J, Vorlat A, Moulijn AC, Vrints CJ. Screening for solid organ malignancies prior to heart transplantation. Transplantation 2001; 71:1481–3.
  • Rosado U, Wild JC, Huston CL, Sethi GK, Copeland JG. Heart-transplantation in patients with treated breast carcinoma. J Heart Lung Transplant 1994; 13: 246–9.
  • Uriel N, Vainrib A, Jorde UP, Cotarlan V. Farr M, Cheema FH, Naka Y, Mancini D, Colombo PC. Mediastinal radiation and adverse outcomes after heart transplantation. J Heart Lung Transplant 2010; 29: 378–381.
  • Ward KM, Binns H, Chin C, Webber SA, Canter CE, Pahl E. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare. J Heart Lung Transplant 2004; 23: 1040–5.
  • Levitt G, Anazodo A, Burch M, Bunch K. Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need? Eur J Cancer 2009; 45: 3027–34.
  • Shah N, Aggarwal S. LEcuyer T. Outcome of heart transplantation in pediatric cancer survivors. Pediatr Transplant 2013; 17: 423–8.
  • Chapman JR, Webster AC, Wong G. Cancer in the transplant patient. Cold Spring Harb Perspect Med 2013; 3.pii: a015677.
  • Mistiaen W, Van Cauwelaert P. Muylaert P. Wuyts Fl, Harrisson F, Border H. Effect of prior malignancy on survival after cardiac surgery. Ann Thorac Surg 2004; 77:1593–7.
  • Mistiaen W. Cancer in heart disease patients: what are the limitations in the treatment strategy? Future Cardiol 2013; 9: 535–47.
  • Alamo JM, Bernal C, Mann LM, Suarez G, Serrano J, Barrera L, Sousa JL, Padillo FJ, Gomez-Bravo M. Antitumor efficacy of mammalian target of rapamycin inhibitor therapy in liver transplant recipients with oncological disease: a case-control study. Transplant Proc 2012; 44:2089–92.
  • Guethoff 5, Meiser BM, Goetzner J, Eifert 5, Grinniger C, Ueberführ P. Reichart B, Hagl C, Kaczmarek I. Ten-year results of a randomized controlled trial comparing tacrolimus versus cyclosporine A in combination with mycophenolate mofetil after heart transplantation. Transplantation 2013; 95:629–34.
  • Stehlik J, Edwards LB, Kucheryavaya, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI. The registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report -2011. J Heart Lung Transpl 2011; 30: 1078–94.
  • Epailly E, Albanell J, Andreassen A, Bara C, Campistol JM, Delgado JF, Eisen H, Fiane AE, Mohacsi P, Schubert S, Sebbag L, Turazza FM, Valantine H, Zuckermann A, Potena L. Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. Clin Transplant 2011; 25: E475–86.
  • Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivrayTE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009; 54: 312–21.
  • Topkara VK, O’Neill JK, Carlisle A, Novak E, Silvestry SC, Ewald GA. HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation:a comparative analysis. Ann Thorac Surg 2014; 97:506–12.
  • Patlolla V, Patten RD, DeNofrio D, Konstam MA, Krishnamani R. The effect of ventricular assist devices on post-transplant mortality. An analysis of the United Network for Organ Sharing Thoracic Registry. J Am Coll Cardiol 2009; 53: 264–71.
  • Willey JS, Demmer RT, Takayama H, Colombo PC, Lazar RM. Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: risk factors, diagnosis and treatment J Heart Lung Transpl 2014; 33: 878–87.
  • Dunning JJ, Mullins PA, Scott JP, Solis E, Schofield PM, Large RS, Wallwork JW. Cardiac transplantation and cancer. Am J Cardiol 1991; 67: 327 [Comment on Cardiac transplantation in patients with preexisting neoplastic diseases. Am J Cardiol 1990]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.